Diagnosis, prevalence, and risk factors of atrophic gastritis

DOI: https://doi.org/10.29296/25877305-2018-10-02
Download full text PDF
Issue: 
10
Year: 
2018

Professor V. Tsukanov, MD; A. Vasyutin, Candidate of Medical Sciences; Yu. Tonkikh, Candidate of Medical Sciences; O. Peretyatko, Candidate of Medical Sciences Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences, Krasnoyarsk

Atrophic gastritis as a precancerous disease is crucial for the early diagnosis and prevention of gastric cancer. The risk factors for atrophic gastritis and gastric cancer are Helicobacter pylori (Hp) infection, male sex, tobacco smoking, the consumption of salted foods and processed meat, as well as hereditary load. The early detection of gastric mucosal atrophy and Hp eradication are of importance in preventing gastric cancer.

Keywords: 
gastroenterology
atrophic gastritis
gastric cancer
Helicobacter pylori
diagnosis
prevalence
risk factors



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Malfertheiner P., Chan F., McColl K. Peptic ulcer disease // Lancet. – 2009; 374 (9699): 1449–61. DOI: 10.1016/S0140-6736(09)60938-7.
  2. Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. – 2015; 148 (4): 719–31. DOI: 10.1053/j.gastro.2015.01.040.
  3. Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. – 2015; 64 (9): 1353–67. DOI: 10.1136/gutjnl-2015-309252.
  4. Malfertheiner P., Megraud F., O'Morain C. et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report // Gut. – 2017; 66 (1): 6–30. DOI: 10.1136/gutjnl-2016-312288.
  5. Rugge M., Genta R., Graham D. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment // Gut. – 2016; 65 (5): 721–5. DOI: 10.1136/gutjnl-2015-310846.
  6. Misiewicz J. The Sydney System: a new classification of gastritis. Introduction // J. Gastroenterol. Hepatol. – 1991; 6 (3): 207–8.
  7. Dixon M., Genta R., Yardley J. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 // Am. J. Surg. Pathol. – 1996; 20 (10): 1161–81.
  8. Rugge M., Correa P., Di Mario F. et al. OLGA staging for gastritis: a tutorial // Dig. Liver Dis. – 2008; 40 (8): 650–8. DOI: 10.1016/j.dld.2008.02.030.
  9. Dinis-Ribeiro M., Areia M., de Vries A. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) // Endoscopy. – 2012; 44 (1): 74–94. DOI: 10.1055/s-0031-1291491.
  10. Liu Y., Ponsioen C., Waverling G. et al. Helicobacter pylori gastritis – a global view. In: Hunt R.H., Tytgat G.N.J. (eds) Helicobacter pylori / Dordrecht: Kluwer academic publishers, 2000; p. 213–20. DOI: 10.1007/978-94-011-3927-4_23.
  11. Shtygasheva O.V., Tsukanov V.V. Assotsiatsija CagA i VacA shtammov Helicobacter pylori i jazvennoj bolezni v organizovannoj populjatsii g. Abakana // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2004; 14 (2): 84–7.
  12. Ageeva E.S., Shtygasheva O.V., Rjazantseva N.V. i dr. Molekuljarno-geneticheskie faktory, vlijajuschie na ishod infitsirovanija Helicobacter pylori u zhitelej Respubliki Hakasija // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2010; 20 (4): 16–21.
  13. Lombardo L., Leto R., Molinaro G. et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test // Clin. Chem. Lab. Med. – 2010; 48 (9): 1327–32. DOI: 10.1515/CCLM.2010.256.
  14. Leja M., Cine E., Rudzite D. et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia // Eur. J. Gastroenterol. Hepatol. – 2012; 24(12): 1410–7. DOI: 10.1097/MEG.0b013e3283583ca5.
  15. Telaranta-Keerie A., Kara R., Paloheimo L. et al. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints // Scand. J. Gastroenterol. – 2010; 45 (9): 1036–41. DOI: 10.3109/00365521.2010.487918.
  16. Benberin V., Bektayeva R., Karabayeva R. et al. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers // Anticancer Res. – 2013; 33 (10): 4595–602.
  17. Toyoda K., Furusyo N., Ihara T. et al. Serum pepsinogen and Helicobacter pylori infection – a Japanese population study // Eur. J. Clin. Microbiol. Infect. Dis. – 2012; 31 (9): 2117–24. DOI: 10.1007/s10096-011-1543-0.
  18. Zou D., He J., Ma X. et al. Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC) // J. Gastroenterol. Hepatol. – 2011; 26 (5): 908–15. DOI: 10.1111/j.1440-1746.2010.06608.x.
  19. Tsukanov V.V., Tret'jakova O.V., Amel'chugova O.S. i dr. Rasprostranennost' atroficheskogo gastrita tela zheludka u naselenija g. Krasnojarska starshe 45 let // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2012; 22 (4): 27–31.
  20. Reshetnikov O.V., Kurilovich S.A., Krotov S.A. i dr. Rasprostranen-nost' atroficheskogo gastrita v raznyh populjatsijah Sibiri po dannym serologicheskogo issledovanija // Klin. meditsina. – 2008; 86 (7): 35–8.
  21. Leont'eva N.I. Gracheva N.M., Novikova L.I. Klinicheskaja otsenka diagnostiki helikobakterioza u bol'nyh s hronicheskoj patologiej zheludochno-kishechnogo trakta diagnosticheskoj test-sistemoj «Gastropanel'» // Eksperim. i klinich. gastroenterol. – 2009; (2, pril. 1): 80.
  22. Roman L., Lukyanchuk R., Sablin O. et al. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg // Anticancer Res. – 2016; 36 (8): 4129–38.
  23. Song J., Kim Y., Heo N. et al. High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia // Cancer Epidemiol. Biomarkers Prev. – 2017; 26 (7): 1133–8. DOI: 10.1158/1055-9965.EPI-16-1024.
  24. Graham D. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits // Gastroenterology. – 2015; 148 (4): 719–31. DOI: 10.1053/j.gastro.2015.01.040.
  25. Fuccio L., Zagari R., Eusebi L. et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? // Ann. Intern. Med. – 2009; 151 (2): 121–8. DOI: 10.7326/0003-4819-151-2-200907210-00009.
  26. Wang J., Xu L., Shi R. et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis // Digestion. – 2011; 83 (4): 253–60. DOI: 10.1159/000280318.
  27. Lee Y., Chen T., Chiu H. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention // Gut. – 2013; 62 (5): 676–82. DOI: 10.1136/gutjnl-2012-302240.
  28. Lee Y., Chiang T., Chou C. et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis // Gastroenterology. – 2016; 150 (5): 1113–24. DOI: 10.1053/j.gastro.2016.01.028.
  29. Malfertheiner P., Megraud F., O'Morain C. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report // Gut. – 2007; 56 (6): 772–81. DOI: 10.1136/gut.2006.101634.
  30. Tsukanov V.V., Amel'chugova O.S., Kasparov E.V. i dr. Rol' eradikatsii Helicobacter pylori v profilaktike raka zheludka // Ter. arh. – 2014; 86 (8): 124–7.